- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Financially Fit Penny Stocks
Global Pharmaceuticals & Biotech Financially Fit Penny Stocks
Results
189
A Penny Stocks screener, typically smaller or younger companies trading at a price below 5, with a focus on solid financial health that should present companies with a lower risk profile than other early-stage businesses
189 companies
Immutep
Market Cap: AU$367.0m
A biotechnology company, engages in developing novel Lymphocyte Activation Gene-3 related immunotherapies for cancer and autoimmune diseases in Australia.
IMM
AU$0.26
7D
2.0%
1Y
-26.1%
Vanda Pharmaceuticals
Market Cap: US$281.3m
A biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide.
VNDA
US$4.90
7D
11.6%
1Y
1.0%
ProKidney
Market Cap: US$806.3m
A clinical-stage biotechnology company, develops a cell therapy platform for the treatment of multiple chronic kidney diseases in the United States.
PROK
US$2.72
7D
7.5%
1Y
32.0%
JSP Pharmaceutical Manufacturing (Thailand) Public
Market Cap: ฿892.2m
JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd.
JSP
฿1.93
7D
5.5%
1Y
-11.5%
Valbiotis
Market Cap: €12.7m
Engages in the research and development of dietary supplements to prevent metabolic and cardiovascular diseases in France.
ALVAL
€0.80
7D
-4.4%
1Y
-38.9%
Nautilus Biotechnology
Market Cap: US$91.6m
A development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome.
NAUT
US$0.72
7D
-0.07%
1Y
-74.5%
Allogene Therapeutics
Market Cap: US$259.6m
A clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer and autoimmune diseases.
ALLO
US$1.23
7D
8.8%
1Y
-53.1%
Covalon Technologies
Market Cap: CA$59.8m
Engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally.
COV
CA$2.15
7D
-1.8%
1Y
-35.8%
Aprea Therapeutics
Market Cap: US$8.4m
A clinical-stage biopharmaceutical company, focuses on developing and commercializing novel synthetic lethality-based cancer therapeutics that targets DNA damage response pathways.
APRE
US$1.42
7D
-5.3%
1Y
-50.5%
Auxly Cannabis Group
Market Cap: CA$195.5m
Operates as a consumer packaged goods company in the cannabis products market in Canada.
XLY
CA$0.15
7D
11.1%
1Y
328.6%
Alector
Market Cap: US$321.9m
A late-stage clinical biotechnology company, develops therapies that is focused on counteracting the devastating progression of neurodegenerative diseases.
ALEC
US$3.16
7D
7.1%
1Y
-35.9%
Cronos Group
Market Cap: CA$1.4b
A cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally.
CRON
CA$3.73
7D
5.4%
1Y
32.3%
PMV Pharmaceuticals
Market Cap: US$73.1m
A precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer.
PMVP
US$1.47
7D
17.6%
1Y
-1.3%
Artiva Biotherapeutics
Market Cap: US$63.3m
A clinical-stage biotechnology company, focuses on developing natural killer (NK) cell-based therapies for patients suffering from autoimmune diseases and cancers.
ARTV
US$2.88
7D
26.3%
1Y
-80.9%
ESSA Pharma
Market Cap: US$9.8m
A clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer.
EPIX
US$0.20
7D
-0.9%
1Y
-96.7%
Connect Biopharma Holdings
Market Cap: US$90.3m
A clinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of inflammatory diseases in the United States.
CNTB
US$1.72
7D
6.8%
1Y
34.4%
Nykode Therapeutics
Market Cap: NOK 516.9m
A clinical-stage biopharmaceutical company, discovers and develops novel immunotherapies for the treatment of cancer and autoimmune diseases.
NYKD
NOK 1.58
7D
5.5%
1Y
-66.0%
Aroa Biosurgery
Market Cap: AU$234.6m
Develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally.
ARX
AU$0.68
7D
-2.2%
1Y
21.4%
Cellectis
Market Cap: €222.0m
A clinical stage biotechnological company, develops products based on gene-editing with a portfolio of allogeneic chimeric antigen receptor T-cells product candidates in the field of immuno-oncology and gene therapy product candidates in other therapeutic indications.
ALCLS
€3.07
7D
13.5%
1Y
60.4%
PharmaCyte Biotech
Market Cap: US$7.3m
A biotechnology company, focused on developing and preparing to commercialize cellular therapies for cancer using live cell encapsulation technology in the United States.
PMCB
US$1.07
7D
10.2%
1Y
-40.6%
HARBIN GLORIA PHARMACEUTICALS
Market Cap: CN¥7.2b
Harbin Gloria Pharmaceuticals Co., Ltd engages in the research, development, production, and sale of pharmaceutical products primarily in the People’s Republic of China.
002437
CN¥3.16
7D
-7.9%
1Y
58.0%
Avecho Biotechnology
Market Cap: AU$22.2m
A biotechnology company, develops and commercializes human and animal health products using its proprietary drug delivery system, tocopherol phosphate mixture (TPM) in Australia, Switzerland, the Americas, and India.
AVE
AU$0.007
7D
0%
1Y
250.0%
Black Diamond Therapeutics
Market Cap: US$180.5m
A clinical-stage oncology company, focuses on the discovery and development of MasterKey therapies for patients with genetically defined tumors.
BDTX
US$3.26
7D
3.2%
1Y
-22.4%
MediciNova
Market Cap: US$62.3m
A biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States.
MNOV
US$1.25
7D
2.5%
1Y
-38.1%
Radiopharm Theranostics
Market Cap: AU$68.6m
Engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical needs.
RAD
AU$0.029
7D
-14.7%
1Y
-6.5%
Futura Medical
Market Cap: UK£11.9m
Research, develops, and commercializes pharmaceutical and healthcare products for sexual health.
FUM
UK£0.039
7D
-55.3%
1Y
-89.0%
Relay Therapeutics
Market Cap: US$767.2m
Operates as a clinical-stage precision medicines company.
RLAY
US$4.52
7D
10.5%
1Y
-36.0%
Werewolf Therapeutics
Market Cap: US$81.9m
A biopharmaceutical company, engages in the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer and other immune-mediated conditions.
HOWL
US$2.08
7D
48.2%
1Y
3.8%
Mereo BioPharma Group
Market Cap: US$286.4m
A biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally.
MREO
US$1.80
7D
4.0%
1Y
-55.0%
Apex Healthcare Berhad
Market Cap: RM 1.8b
An investment holding company, engages in the development, manufacture, marketing, distribution, and wholesale of pharmaceutical and healthcare products in Malaysia, Singapore, and internationally.
AHEALTH
RM 2.43
7D
-0.4%
1Y
-11.6%
Genetic Signatures
Market Cap: AU$62.5m
Operates as a molecular diagnostic company in Australia, the Asia Pacific, Europe, the Middle East, Asia, and the Americas.
GSS
AU$0.27
7D
3.9%
1Y
-60.4%
Organogenesis Holdings
Market Cap: US$603.8m
A regenerative medicine company, develops, manufactures, and commercializes products for the advanced wound care, and surgical and sports medicine markets in the United States.
ORGO
US$4.90
7D
6.1%
1Y
76.9%
Medicenna Therapeutics
Market Cap: CA$85.1m
A clinical-stage immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer, inflammation, and immune-mediated diseases.
MDNA
CA$0.96
7D
-5.0%
1Y
-47.8%
C4 Therapeutics
Market Cap: US$184.3m
A clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins.
CCCC
US$2.42
7D
-28.4%
1Y
-61.3%
Sanai Health Industry Group
Market Cap: HK$64.2m
An investment holding company, engages in the manufacture, marketing, and sale of branded prescription and non-prescription drugs, and Chinese pharmaceutical products in the People’s Republic of China and Hong Kong.
1889
HK$0.41
7D
-5.7%
1Y
86.4%
Ovoca Bio
Market Cap: UK£938.0k
A clinical-stage biopharmaceutical company, develops and commercializes novel product candidates for women health.
OVB
UK£0.011
7D
0%
1Y
39.4%